Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling (Q24673299)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling |
scientific article |
Statements
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling (English)
Debasmita Roy
Ling Wang
Farnaz D Fakhari
Dhavalkumar D Patel
David Henry
William J Harrington
Blossom A Damania
2 November 2006
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references